Member of the Board of Directors, Finance, Audit, Compliance
Martin Scholl was elected to the Board of Directors of InnoMedica in 2025. He worked at Zürcher Kantonalbank for 45 years, where he was CEO from 2007 to 2022. He has held various positions, including as a member of the Board of Directors of the Swiss Bankers Association and the Economiesuisse business association, as well as Vice Chairman of the Association of Swiss Cantonal Banks. weitere Positionen inne, unter anderem war er Verwaltungsrat der Schweizerischen Bankiervereinigung und des Wirtschaftsverbandes Economiesuisse sowie Vizepräsident des Verbands Schweizerischer Kantonalbanken.
Sein Engagement für Start-ups zeigt sich in seinen Verwaltungsratsmandaten bei Verve Ventures His commitment to start-ups is reflected in his board memberships at Verve Ventures and IPZ Property AG (Switzerland Innovation Park Zurich).
